Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what the existing weekly capacity for vaccine production is in the UK.
The UK has a strong manufacturing basis in vaccines and life sciences, with a range of sites around the country.
Through the Vaccine Taskforce, the Government has entered commercial arrangements with a number of these sites to manufacture and fill-finish COVID-19 vaccines. The Government has also invested over £230 million in expanding the UK’s vaccine manufacturing base, through several investments, such as the Vaccines Manufacturing and Innovation Centre and Cell and Gene Manufacturing and Innovation Centre.